Literature DB >> 12875967

Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene.

Heng Wang1, John Hicks, Parham Khanbolooki, Sun-Jin Kim, Chunhong Yan, Yao Wang, Douglas Boyd.   

Abstract

The urokinase-type plasminogen activator receptor (u-PAR) contributes to cell migration and proteolysis in normal and cancerous tissues. Currently, there are no reports on the regulatory regions directing tissue-specific expression. Consequently, we undertook a study to identify novel promoter regions required for expression of this gene in transgenic mice bearing a LacZ reporter regulated by varying amounts (0.4, 1.5, and 8.5 kb) of upstream sequence. The 0.4-kb u-PAR upstream sequence directed weak and strong LacZ expression in the placenta and epididymis, respectively, both of which are tissues that express endogenous u-PAR. Conversely, transgene expression in the apical cells of the colon positive for endogenous u-PAR protein required 1.5 kb of upstream sequence for optimal expression. Furthermore, chromatin accessibility assays coupled with real-time polymerase chain reaction suggested a putative regulatory region spanning -1295/-1192 driving u-PAR expression in colonic cells. Interestingly, placental transgene expression was augmented with the 8.5-kb upstream fragment compared with the shorter 1.5-kb fragment indicating contributing element(s) between -1.5 and -8.5 kb. Thus, while 0.4 kb of upstream sequence directs u-PAR expression in the epididymis, sequences located between -0.4 and -1.5 kb and between -1.5 and -8.5 kb are required for optimal tissue-specific expression in the colon and the placenta, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875967      PMCID: PMC1868205          DOI: 10.1016/S0002-9440(10)63675-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

1.  Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription.

Authors:  A S Weinmann; S E Plevy; S T Smale
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

2.  Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor.

Authors:  Y Wang; J Dang; H Wang; H Allgayer; G A Murrell; D Boyd
Journal:  Eur J Biochem       Date:  2000-06

3.  The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling.

Authors:  H Solberg; M Ploug; G Høyer-Hansen; B S Nielsen; L R Lund
Journal:  J Histochem Cytochem       Date:  2001-02       Impact factor: 2.479

4.  beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter.

Authors:  S Hapke; M Gawaz; K Dehne; J Köhler; J F Marshall; H Graeff; M Schmitt; U Reuning; E Lengyel
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  Gene expression patterns associated with the metastatic phenotype in rodent and human tumors.

Authors:  A Nestl; O D Von Stein; K Zatloukal; W G Thies; P Herrlich; M Hofmann; J P Sleeman
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

6.  Two 5'-regions are required for nutritional and insulin regulation of the fatty-acid synthase promoter in transgenic mice.

Authors:  Y S Moon; M J Latasa; K H Kim; D Wang; H S Sul
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

7.  Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression.

Authors:  M E Kupferman; M E Fini; W J Muller; R Weber; Y Cheng; R J Muschel
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

8.  The upstream region of the Rpe65 gene confers retinal pigment epithelium-specific expression in vivo and in vitro and contains critical octamer and E-box binding sites.

Authors:  A Boulanger; S Liu; A A Henningsgaard; S Yu; T M Redmond
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

9.  A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin.

Authors:  K Mishima; A P Mazar; A Gown; M Skelly; X D Ji; X D Wang; T R Jones; W K Cavenee; H J Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

10.  Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during developmental and injury-related tissue remodeling.

Authors:  R Mohan; W B Rinehart; P Bargagna-Mohan; M E Fini
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

View more
  2 in total

1.  Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models.

Authors:  Meritxell Huch; Alena Gros; Anabel José; Juan Ramon González; Ramon Alemany; Cristina Fillat
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

2.  Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder.

Authors:  Daniel B Campbell; Chun Li; James S Sutcliffe; Antonio M Persico; Pat Levitt
Journal:  Autism Res       Date:  2008-06       Impact factor: 5.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.